Recombinant Human Thrombopoietin Recruiting Phase 4 Trials for Primary Immune Thrombocytopenia (ITP) Treatment

IndicationsStatusPurposePhase
RecruitingTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT03771378Efficacy and Safety of rhTPO and Eltrombopag in Patients With Primary Immune Thrombocytopenia (ITP)